Kolexia
Hivert Benedicte Hématologie
Hivert Benedicte
Hématologie
Hôpital Saint Vincent de Paul Lille
Lille, France
89 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Macroglobulinémie de Waldenström Maladie de Gaucher Lymphomes Leucémies Lymphome B diffus à grandes cellules Leucémie chronique lymphocytaire à cellules B Leucémie lymphoïde Lymphome B Maladies rares

Collaborateurs

Voir plus
Pascal Laurent
Pascal Laurent
Faculte De Medecine Et Maïeutique, Lille, France
Morel Pierre
Morel Pierre
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France
Carpentier Benjamin
Carpentier Benjamin
Hôpital Saint Vincent de Paul Lille, Lille, France
Delmer Alain
Delmer Alain
Hôpital Robert-Debré Reims, Reims, France

Industries

Voir plus
Janssen
18 collaboration(s)
Dernière en 2023
AstraZeneca
6 collaboration(s)
Dernière en 2022
Abbvie
3 collaboration(s)
Dernière en 2022
Sanofi
3 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia: Efficacy of First Line Dexamethasone, Rituximab and Cyclophosphamide (DRC) +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Essai Clinique (University of Ulm)   29 novembre 2023
Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Interim Results of MRD Kinetics in the Eradic Trial from the Filo Group
65th ASH Annual Meeting Abstracts   02 novembre 2023
SérieProWM: Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease: Validation of International Prognostic Indexes, Evaluation of Progression-free Survival as a Surrogate Endpoint for Overall Survival
Essai Clinique (French Innovative Leukemia Organisation)   28 août 2023
Autologous and allogeneic stem-cell transplantation for transformed Waldenström macroglobulinemia
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
STAIR: STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia
Essai Clinique (French Innovative Leukemia Organisation)   23 mai 2023
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   10 février 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
American journal of hematology   01 janvier 2023
Blinatumomab for Patients with Richter Syndrome: Final Results of the Phase 2 Blinart Trial from the Filo Group
Annual Meeting Abstracts 2022   15 novembre 2022
Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation
Annual Meeting Abstracts 2022   15 novembre 2022
Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype
Annual Meeting Abstracts 2022   15 novembre 2022